Share Issuance
The information and documents on this section of Heliospectra’s website are not intended for, and may not, directly or indirectly, be accessed by, or distributed, published or disseminated in or into the USA, Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Switzerland, Singapore, South Africa, South Korea or any other jurisdiction where such action would violate applicable laws or regulations or would require additional documentation to be prepared or registered or require any other action to be taken, in addition to the requirements under Swedish law. We therefore ask you to review the information under the heading “Important Information” (see bottom of this page) each time you wish to access this section of Heliospectra’s website to ensure that you are authorized to access the information and documents on this section of the website. Please note that the terms under the heading “Important Information” may be changed or updated and that it is therefore important that you read them each time you visit this section of the website. If you are prevented from accessing the information and material on this section of the website or if you are uncertain as to whether you are authorized to access this, please leave this section of Heliospectra’s website.
Heliospectra conducts partially guaranteed rights issue of shares
Heliospectra announced on September 29 that the Company’s board of directors proposes a new issue of shares with preferential rights for existing shareholders (the “Rights Issue”).
If fully subscribed, the Rights Issue will provide Heliospectra with approximately SEK 49.5 million before costs related to the Rights Issue. The subscription price has been set at SEK 0.10 per share. Anyone who is entered in the share register as a shareholder in Heliospectra on the record date of November 3, 2025 will receive nine (9) subscription rights for each (1) share held in the Company. The subscription period for the Rights Issue runs from November 5, 2025 to November 19, 2025.
Heliospectra has received a subscription commitment from the Company’s largest shareholder Weland Stål AB (“Weland”) amounting to SEK 30 million, corresponding to approximately 60.6 percent of the Rights Issue.
Full terms and conditions and instructions for the Rights Issue will be set out in the information document published on 4 November 2025 at 09:45.
Background and reasons
Heliospectra has now successfully finalised the Company’s product portfolio with focus on Agtech and greenhouse market, marking an important milestone for the Company. Thus, Heliospectra is well positioned to take the next step in the development and establish itself as a leading player in the industry. To achieve this, increased investments in commercial activities such as marketing and sales are required. The Company is driven by ambition to strengthen its market position and create growth for its products and solutions. A key part of this development is the introduction of HelioSENSE, the Company’s patented and unique biofeedback sensor, which further underscores Heliospectra’s innovation capabilities and offers growers worldwide a clear added value.
Upon full subscription of the Rights Issue, the Company will receive approximately SEK 49.5 million before deduction of transaction costs. The net proceeds will primarily be used to strengthen the Heliospectra’s commercial incentives. This includes strategic investments in marketing efforts, expansion of the sales organization, and increased presence in prioritized markets. It also includes preparatory activities for the planned launch of HelioSENSE in the second quarter of 2026. Additionally, part of the capital will be used to streamline the Company’s operational processes and ensure the capacity to meet the growing demand from costumers.
Documents:
Important information
Due to legal restriction, access to the information and documents on this section of Heliospectra AB’s (publ) (the “Company”) website is restricted. We kindly ask you to review the following information each time you wish to access this section of the Company’s website, to ensure that you are authorized to access the information and documents on this section of the website. Please note that the terms set out below may be altered or updated and therefore it is important that you review them in full each time you visit this section of the Company’s website.
This section of the Company’s website, and the information and documents contained herein, is not intended for, and may not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions), Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, Switzerland, South Africa, South Korea, or any other jurisdiction where distribution would require prospectuses, registration measures, or other measures in addition to those required by Swedish law or otherwise would be in conflict with the rules of such jurisdiction or which cannot be made without application of exemptions in such jurisdiction. This section of the Company’s website, and the information and documents contained herein, do not constitute an offer to sell or the solicitation of an offer to purchase, subscribe, or acquire, any shares, subscription rights, paid subscribed shares, or other securities in the Company (“Securities”) to any person in said jurisdictions. The information and documents on this section of the Company’s websites may not be forwarded or reproduced in such a manner that contravenes such restrictions or would give cause to such requirements.
No Securities have been registered or will be registered under the United States Securities Act of 1933 as amended (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States of America and may not be offered, subscribed for, used, pledged, sold, resold, allotted, delivered, or otherwise transferred, directly or indirectly, in or into the United States of America except under an available exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States of America. No public offering of the Securities is being made in the United States of America.
With respect to the member states of the European Economic Area (the “EEA”), other than Sweden, which have implemented the regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 (together with any amendments thereto and any related implementing and delegated regulations, the “Prospectus Regulation”) (each a “Relevant Member State”), no action has been undertaken or will be undertaken to make an offer to the public of Securities requiring a publication of a prospectus in any Relevant Member State. As a consequence, Securities may only be acquired in any Relevant Member State pursuant to an exemption under the Prospectus Regulation. This section of the Company’s website, and the information and documents contained herein, are only distributed to and only directed at “qualified investors” within the meaning of the Prospectus Regulation. In other member states of the EEA which have not implemented the Prospectus Regulation in its national legislation, any offer of Securities may only be made in accordance with an applicable exemption under national law.
This section of the Company’s website, and the information and documents contained herein, are directed solely at persons (i) who are outside the United Kingdom, (ii) who have professional experience in matters relating to investments and who fall within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”), or (iii) who are high net worth entities and other persons to whom such website and the information contained herein may otherwise lawfully be communicated falling within Article 49(2) of the Order (all such persons together being referred to as “Relevant Persons”). This section of the Company’s website, and the information and documents contained herein must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this section of the Company’s website and the information contained herein relate is available only to Relevant Persons and will be engaged in only with Relevant Persons.
All persons residing outside of Sweden who wish to access the information and documents contained on this section of the Company’s website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this section of the Company’s website, or require registration or approval for any acquisition of Securities by them. No such registration or approval has been obtained outside Sweden. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.
If you are not permitted to view materials on this section of the Company’s website or are in any doubt as to whether you are permitted to view these materials, please exit this section of the Company’s website.
Access to electronic versions of these materials is being made available on this section of the website by the Company in good faith and for information purposes only. While the Company believes that the information posted on this section of the Company’s website is accurate and complete as of the posted date, and while the Company may post new information from time to time, the Company does not assume any obligation to update or correct such information and explicitly disclaims any duty to do so.
By accessing the information and documents on this section of the Company’s website, you confirm and certify that (i) you have read and accepted the terms and restrictions set out above; (ii) you are not a resident of or physically present in any of the above-mentioned jurisdictions or any other restricted jurisdiction and are not a U.S. person (as defined in Regulation S under the Securities Act); and (iii) you are either (a) a resident of or physically present in Sweden, (b) if resident or physically present in a Relevant Member State, a qualified investor as defined in Prospectus Regulation, or (c) otherwise authorized to access this information and documents pursuant to applicable laws or regulations.
IR Contact
Rebecca Nordin
Head of IR
+46 (0)72 536 8116
ir@heliospectra.com
Certified Adviser
Redeye
+46 (0)8 121 576 90
Certifiedadviser@redeye.se

